GENB smart money
Generate Biomedicines, INC. (GENB): 3 insider buys, 5 top funds holding it, 1 ETF change in the public filings.
Insider buys, 12 months$50.2M
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-03-06 | Nally Michael | Chief Executive Officer | $240k | $12.0 |
| 2026-03-02 | Nutritional Health Ltp Fund General Partner LLC | TenPercentOwner | $25.0M | $16.0 |
| 2026-03-02 | Flagship Pioneering Fund Vi, L.P. | TenPercentOwner | $25.0M | $16.0 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 22 | Braidwell LP | TRIM -10% | 1.92% | $44M |
| 30 | Deep Track Capital, LP | ADD +88% | 0.63% | $38M |
| 31 | Affinity Asset Advisors, LLC | TRIM -75% | 0.09% | $2M |
| 50 | Siren, L.L.C. | 0.26% | $11M | |
| 71 | Baker Bros. Advisors LP | 0.10% | $21M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| Ark Genomic Revolution ETF | ADD | +$10M | 2026-07-31 |